Raising Capital in a Highly Regulated Market
Healthcare Law Insights blog
MARCH 12, 2025
What Investors Look for in Early and Late-Stage Funding Rounds and How Regulatory Compliance Impacts Valuation For early-stage life sciences and health tech companies, raising capital is about more than demonstrating scientific promise. Regulatory and IP disputes over data usage can create obstacles to commercialization.
59 
Let's personalize your content